Literature DB >> 22245658

Tamsulosin exposure is significantly increased by the CYP2D6*10/*10 genotype.

Chang-Ik Choi1, Jung-Woo Bae, Choon-Gon Jang, Seok-Yong Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22245658     DOI： 10.1177/0091270011432168

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  8 in total

1.  Relationship between plasma exposure of zolpidem and CYP2D6 genotype in healthy Korean subjects.

Authors:  Eui Hyun Jung; Choong-Min Lee; Ji-Yeong Byeon; Hyo-Bin Shin; Kyung-Yul Oh; Chang-Keun Cho; Chang Woo Lim; Choon-Gon Jang; Seok-Yong Lee; Yun Jeong Lee
Journal:  Arch Pharm Res       Date:  2020-07-13       Impact factor: 4.946

2.  Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans.

Authors:  Kyoung-Ah Kim; In-Bae Park; Ji-Young Park
Journal:  Eur J Clin Pharmacol       Date:  2018-06-13       Impact factor: 2.953

Review 3.  Precision medicine: does ethnicity information complement genotype-based prescribing decisions?

Authors:  Rashmi R Shah; Andrea Gaedigk
Journal:  Ther Adv Drug Saf       Date:  2017-12-01

4.  Human hepatocytes and cytochrome P450-selective inhibitors predict variability in human drug exposure more accurately than human recombinant P450s.

Authors:  Bo Lindmark; Anna Lundahl; Kajsa P Kanebratt; Tommy B Andersson; Emre M Isin
Journal:  Br J Pharmacol       Date:  2018-04-19       Impact factor: 8.739

5.  Physiologically based pharmacokinetic modelling to predict the pharmacokinetics of metoprolol in different CYP2D6 genotypes.

Authors:  Choong-Min Lee; Pureum Kang; Chang-Keun Cho; Hye-Jung Park; Yun Jeong Lee; Jung-Woo Bae; Chang-Ik Choi; Hyung Sik Kim; Choon-Gon Jang; Seok-Yong Lee
Journal:  Arch Pharm Res       Date:  2022-06-28       Impact factor: 4.946

6.  Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin related to CYP2D6*10 allele.

Authors:  Pureum Kang; Hye-Jung Park; Chang-Keun Cho; Yun Jeong Lee; Jung-Woo Bae; Choon-Gon Jang; Seok-Yong Lee
Journal:  Arch Pharm Res       Date:  2021-11-09       Impact factor: 4.946

Review 7.  Challenges to assess substrate-dependent allelic effects in CYP450 enzymes and the potential clinical implications.

Authors:  Lauren A Marcath; Amy L Pasternak; Daniel L Hertz
Journal:  Pharmacogenomics J       Date:  2019-10-15       Impact factor: 3.550

8.  Where Failure Is Not an Option -Personalized Medicine in Astronauts.

Authors:  Julia C Stingl; Susanne Welker; Gunther Hartmann; Volker Damann; Ruppert Gerzer
Journal:  PLoS One       Date:  2015-10-21       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.